An overview of cyclopropenone derivatives as promising bioactive molecules
- PMID: 38852789
- DOI: 10.1016/j.bmcl.2024.129845
An overview of cyclopropenone derivatives as promising bioactive molecules
Abstract
Cyclopropenone is a valuable electrophilic reagent that can react with electrophilic reagents, nucleophilic reagents, free radicals, organic metals, etc. Furthermore, cyclopropenone derivatives have shown significant biological activity in various diseases, such as triple-negative breast cancer (TNBC), melanoma, and alopecia areata (AA). The cyclopropenone analogue diphenylcyclopropenone (DPCP) has been approved for the treatment of AA. Given the potential therapeutic benefits of cyclopropenone derivatives, this review aims to systematically summarize the structures, synthesis routes, and potential pharmacological functions of cyclopropenone analogues in the hope of offering novel insights for further rational design of more drugs based on the cyclopropenone skeleton for the treatment of human diseases.
Keywords: Alopecia areata; Cyclopropenone; Diphenylcyclopropenone; Melanoma; Triple negative breast cancer.
Copyright © 2024 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Novel Electrophilic Warhead Targeting a Triple-Negative Breast Cancer Driver in Live Cells Revealed by "Inverse Drug Discovery".J Med Chem. 2021 Nov 11;64(21):15582-15592. doi: 10.1021/acs.jmedchem.0c02024. Epub 2021 Oct 8. J Med Chem. 2021. PMID: 34623802
-
Serum level of IL-4 predicts response to topical immunotherapy with diphenylcyclopropenone in alopecia areata.Exp Dermatol. 2020 Mar;29(3):231-238. doi: 10.1111/exd.13758. Epub 2018 Aug 29. Exp Dermatol. 2020. PMID: 30047620
-
Diphenylcyclopropenone plays an effective therapeutic role by up-regulating the TSLP/OX40L/IL-13 pathway in severe alopecia areata.Exp Dermatol. 2021 Feb;30(2):278-283. doi: 10.1111/exd.14254. Epub 2020 Dec 15. Exp Dermatol. 2021. PMID: 33325128
-
Advances in small-molecule drug discovery for triple-negative breast cancer.Future Med Chem. 2015;7(15):2019-39. doi: 10.4155/fmc.15.129. Epub 2015 Oct 23. Future Med Chem. 2015. PMID: 26495746 Review.
-
Efficacy of topical sensitizers in the treatment of alopecia areata.J Am Acad Dermatol. 1998 Nov;39(5 Pt 1):751-61. doi: 10.1016/s0190-9622(98)70048-9. J Am Acad Dermatol. 1998. PMID: 9810892 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources